HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations

被引:122
作者
Spurkland, A [1 ]
Saarinen, S
Boberg, KM
Mitchell, S
Broome, U
Caballeria, L
Ciusani, E
Chapman, R
Ercilla, G
Fausa, O
Knutsen, I
Pares, A
Rosina, F
Olerup, O
Thorsby, E
Schrumpf, E
机构
[1] Natl Hosp Norway, Inst Immunol, N-0027 Oslo, Norway
[2] Karolinska Inst, Huddinge Hosp, Unit Gastroenterol & Hepatol, S-10401 Stockholm, Sweden
[3] Molinette Mauriziano Hosp, Dept Gastroenterol, Turin, Italy
[4] John Radcliffe Hosp, Dept Med, Oxford OX3 9DU, England
[5] Univ Barcelona, Hosp Clin & Prov, Liver Unit, Barcelona, Spain
[6] Univ Barcelona, Hosp Clin & Prov, Serv Immunol, Barcelona, Spain
[7] Inst Naz Neurol, Dept Neurol, Milan, Italy
[8] Univ Oslo, Natl Hosp, Dept Med, Oslo, Norway
来源
TISSUE ANTIGENS | 1999年 / 53卷 / 05期
关键词
disease susceptibility genes; HLA class II genes; primary sclerosing cholangitis;
D O I
10.1034/j.1399-0039.1999.530502.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The association of primary sclerosing cholangitis (PSC) to HLA class II genes was studied by comparing patients from five different European populations. Deduced HLA-DRB1, DQA1, DQB1 haplotypes of 256 PSC patients from England, Italy, Norway, Spain and Sweden were compared to those observed in 764 ethnically-matched controls. Increased frequencies of the DRB1*03, DQA1"0501, DQB1*02 (RR=3.0, P<0.00001) and the DRB1*13, DQA1*0103, DQB1*0603 haplotypes (RR=2.4, P<0.0001) were observed in all five patient groups. A total of 16% of the PSC patients were homozygous for the DRB1*03, DQA1*0501, DQB1*02 haplotype compared to 1% of the controls (RR=20, P<0.0001). The DRB1*04, DQA1*03, DQB1*0302 haplotype was significantly reduced in frequency (RR=0.4, P<0.00001). Among Nor wegian, Swedish and British patients that did not carry neither the DRB1*03, DQA1"0501, DQB1*02 nor die DRB1*13 DQA1*0103, DQB1*0603 haplotype, an increased frequency of the DRB1*15, DQA1*0102, DQB1*0602 haplotype was observed (RR=2.0, P<0.0001). Thus, PSC was found to be positively associated to three different HLA class II haplotypes (i.e. the DRB1*03, DQA1*0501, DQB1*02, the DRB1*15, DQA1*0102, DQB1*0602 and the DRB1*13, DQA1*0103, DQB1*0603 haplotypes) and negatively associated to one HLA class II haplotype (i.e. the DRB1*04, DQB1*0302 haplotype).
引用
收藏
页码:459 / 469
页数:11
相关论文
共 45 条
[21]  
NOGUCHI K, 1992, TRANSPLANT P, V24, P2775
[22]   HLA-DR AND HLA-DQ ARE NOT MARKERS FOR RAPID DISEASE PROGRESSION IN PRIMARY SCLEROSING CHOLANGITIS [J].
OLERUP, O ;
OLSSON, R ;
HULTCRANTZ, R ;
BROOME, U .
GASTROENTEROLOGY, 1995, 108 (03) :870-878
[23]   HLA-DR TYPING BY PCR AMPLIFICATION WITH SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) IN 2 HOURS - AN ALTERNATIVE TO SEROLOGICAL DR TYPING IN CLINICAL-PRACTICE INCLUDING DONOR-RECIPIENT MATCHING IN CADAVERIC TRANSPLANTATION [J].
OLERUP, O ;
ZETTERQUIST, H .
TISSUE ANTIGENS, 1992, 39 (05) :225-235
[24]  
OLERUP O, 1991, NEW ENGL J MED, V325, P1251
[25]  
PARK MS, 1991, NEW ENGL J MED, V325, P1252
[26]   ON THE HLA-DQ(ALPHA-1-ASTERISK-0501, BETA-1-ASTERISK-0201)-ASSOCIATED SUSCEPTIBILITY IN CELIAC-DISEASE - A POSSIBLE GENE DOSAGE EFFECT OF DQB1-ASTERISK-0201 [J].
PLOSKI, R ;
EK, J ;
THORSBY, E ;
SOLLID, LM .
TISSUE ANTIGENS, 1993, 41 (04) :173-177
[27]   ASSOCIATION OF PRIMARY SCLEROSING CHOLANGITIS WITH HLA-DRW52A [J].
PROCHAZKA, EJ ;
TERASAKI, PI ;
PARK, MS ;
GOLDSTEIN, LI ;
BUSUTTIL, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (26) :1842-1844
[28]   HLA class II gene frequencies in Crohn's disease: A population based analysis in Germany [J].
Reinshagen, M ;
Loeliger, C ;
Kuehnl, P ;
Weiss, U ;
Manfras, BJ ;
Adler, G ;
Boehm, BO .
GUT, 1996, 38 (04) :538-542
[29]   Genetic markers may predict disease behavior in patients with ulcerative colitis [J].
Roussomoustakaki, M ;
Satsangi, J ;
Welsh, K ;
Louis, E ;
Fanning, G ;
Targan, S ;
Landers, C ;
Jewell, DP .
GASTROENTEROLOGY, 1997, 112 (06) :1845-1853
[30]  
Sambrook J., 1989, MOL CLONING